CDER’s Neurology Division Prepares For New Leadership With Director Katz’s Retirement
Russell Katz will retire following a 30-year career at FDA; his departure comes as the agency is embarking on new efforts to encourage drug development for Alzheimer’s disease and amyotrophic lateral sclerosis.